BAYER : NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas

Press/Media

Period	3 Apr 2018

Media coverage

Title	BAYER : NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas
Media name/outlet	4 Traders
Country/Territory	United States
Date	3/04/18
URL	www.4-traders.com/BAYER-436063/news/Bayer-NIH-funded-study-shows-sorafenib-improves-progression-free-survival-for-patients-with-rare-s-26273973/
Persons	Gary Schwartz